Exact Mass: 688.3094758
Exact Mass Matches: 688.3094758
Found 82 metabolites which its exact mass value is equals to given mass value 688.3094758
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Halistanol sulfate
C29H52O12S3 (688.2620751999999)
Encequidar
C38H36N6O7 (688.2645345999999)
4-O-methylbutin-7-O-[(6->1)-3,11-dimethyl-7-hydroxymethylenedodecanyl]-beta-D-glucopyranoside
aeruginosin DA642B|D-o-Cl-Hpla-D-Leu-L-Choi-6-sulfate-agmatine
C29H45ClN6O9S (688.2657110000001)
rel-(4aR,6R,6aR,7S,8S,10R,11aR,12R,12aS,12bR)-5,6,6a,7,8,10,11a,12,12a-decahydro-11a-(1-hydroxy-1-methylethyl)-3,3,6a,9-tetramethyl-1H-azuleno[5,5-f][1,3]benzodioxin-6,7,8,10,12,12b(4aH)-hexol 6,7,12-triacetate 8-benzoate|sumataxin C
furost-25(27)-en-1beta,2beta,3beta,4beta,5beta,7alpha,22,26-octaol-6-one 26-O-beta-D-glucopyranoside
30,30,34,34-tetrachlorocylindrocyclophane F|cylindrocyclophane F4
2-ethylhexyl 6,6-dibutyl-14-ethyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadeca-2,9-dienoate
C32H56O8Sn (688.2996966000001)
Tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaene-5,11-diylbis[bis(3,5-dimethylphenyl)phosphine]
N4,N4-Di-1-naphthalenyl-N4,N4-di-2-naphthalenyl-[1,1-biphenyl]-4,4-diamine
N,N-[2,5-O-DI-2-Fluoro-benzyl-glucaryl]-DI-[1-amino-indan-2-OL]
C38H38F2N2O8 (688.2596092000001)
4-[(10S,14S,18S)-18-(2-Amino-2-oxoethyl)-14-(1-naphthylmethyl)-8,17,20-trioxo-7,16,19-triazaspiro[5.14]icos-11-EN-10-YL]benzylphosphonic acid
Vionactane
C25H46N13O10+3 (688.3490436000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
(R)-1-(threo-4-Hydroxy-L-3,6-diaminohexanoic acid)-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]viomycin
C25H46N13O10+3 (688.3490436000001)
Viomycin(3+)
C25H46N13O10+3 (688.3490436000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
N-[[(3S,9R,10S)-16-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide
[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA)
C28H39F3N8O9 (688.2791960000001)
Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) (Cyclo(RGDfV) (TFA))is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) can be used for the research of acute myeloid leukemia[1].
20,21-bis(acetyloxy)-6-(furan-3-yl)-4,12,19-trihydroxy-5,11,15,16-tetramethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate
(2s,3as,6r,7as)-n-(4-carbamimidamidobutyl)-1-[(2r)-2-{[(2r)-3-(3-chloro-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl]-6-(sulfooxy)-octahydroindole-2-carboximidic acid
C29H45ClN6O9S (688.2657110000001)
[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{4-[(2s,3r)-4-hydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-(hydroxymethyl)butyl]-2-methoxyphenoxy}oxan-2-yl]methyl 3,4-dimethoxybenzoate
[9a,11a-dimethyl-7,8-bis(sulfooxy)-1-(5,6,6-trimethylheptan-2-yl)-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid
C29H52O12S3 (688.2620751999999)
methyl (2s)-2-(acetyloxy)-2-[(1r,2s,5r,6s,10s,11s,12r,13s,14r,15s,17r,18r)-12,14,17-tris(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]acetate
methyl (2s)-2-(acetyloxy)-2-[(1s,2r,5r,6r,10r,11s,12r,13s,14r,15r,17s,18s)-12,14,17-tris(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]acetate
methyl 2-[(1r,2r,5r,6r,11r,12r,13r,14s,16s)-12,14-bis(acetyloxy)-6-(furan-3-yl)-13-hydroxy-11-[(isopropoxycarbonyl)oxy]-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]acetate
n-[(3r,4s,7s,10r,15as)-5,8-dihydroxy-7,10-bis(1h-indol-3-ylmethyl)-3-methyl-1,11-dioxo-3h,4h,7h,10h,13h,14h,15h,15ah-pyrrolo[2,1-c]1-oxa-4,7,10-triazacyclotridecan-4-yl]-2-phenylethanimidic acid
C39H40N6O6 (688.3009180000001)